Antiretroviral therapy for HIV infection in infants and children : towards universal access : | recommendations for a public health approach / WHO - Worl Health Organization (Record no. 24420)
[ view plain ]
| 000 -CABECERA | |
|---|---|
| campo de control de longitud fija | 03552nam a22005057a 4500 |
| 008 - LONGITUD FIJA | |
| campo de control de longitud fija | 140202b ck ||||| |||| 00| 0 spa d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER | |
| ISBN | 92 4 159469 1 -- 978 92 4 159469 1 |
| 100 1# - AUTOR PERSONAL | |
| nombre | WHO - World Health Organization |
| 9 (RLIN) | 90899 |
| 245 10 - TÍTULO PROPIAMENTE DICHO | |
| título | Antiretroviral therapy for HIV infection in infants and children : towards universal access : |
| 245 10 - TÍTULO PROPIAMENTE DICHO | |
| título | recommendations for a public health approach / WHO - Worl Health Organization |
| 264 ## - PIE DE IMPRENTA | |
| lugar (ciudad) | Ginebra : WHO - World Health Organization, 2007 |
| 300 ## - DESCRIPCIÓN FÍSICA | |
| Extensión | iv, 144 p. : tablas ; 24 x 16 cm. |
| 490 0# - SERIE | |
| serie | HIV/AIDS Programme : Strengthening health services to fight HIV/AIDS |
| 9 (RLIN) | 97149 |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | Objetives of the guidelines -- Development of the guidelines -- Establishing diagnosis of HIV infection - |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | When to Start Antiretroviral Therapy in Infants and Children -- What to Start - Recommended first-Line ARV |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | Regimens in Infants and Children -- Considerations for ART in Infants Previously Exposed to ARV Drugs |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | --Atiretroviral drug Toxicity -- Substituting whithin a First-line ARV Regimen in Infants and CHILDREN because |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | of Drug Toxicity -- Sitching an ARV Regimen in Infants and Children. Treatment Failure -- Choise of ARV |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | Regimens in the Event of Treatment Failure of First-Line Regimens in Infants and Children - Second-Line |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | Regimens -- Considerations for infants and children Coinfected With Tuberculosis and HIV -- Considerations for |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | Nutrition in HIV-infected Infants and Children -- Considerations for ART in Adolescents -- Clinical and |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | Laboratory Monitoring -- Adherence to ART -- Strategies in the Event of Failure of Second-Line Regimens -- |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | Drug Resistance -- Members of the technical reference group on paediatric HIV care and treatment -- WHO |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | clinical staging of HIV for infants and children with established HIV infection -- Presumptive and definitive |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | criteria for recognizing HIV related clinical events in infants and children with established HIV infection -- |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | WHO classification of HIV-associated immunodeficency in infants and children -- 12 Month mortality risk at |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | selected thresholds for %CD4+, absolute CD4 count and total lymphocyte count by age -- Prescribing information |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | and weight based dosing of available ARV formulations for infants and children -- Seroius acute and chronic |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | toxicities caused by ARV drugs, possibly requiring therapy modification: clinical preenation, laboratory |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | abnormalities and implications for ART management -- Severity grading of selected clinical and laboratory |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | toxicities most commonly seen with recommended ARV drugs for children -- Sexual maturity rating (Tanner |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | staging) in adolescents -- Recommended tiered laboratory capabilities for ART monitoring in resource-limited s |
| 505 00 - NOTA DE CONTENIDO | |
| Nota de contenido | settings -- References -- |
| 700 1# - COAUTOR PERSONAL | |
| Nombre de persona | OMS - Organización Mundial de la Salud (Ginebra) |
| 9 (RLIN) | 71253 |
| 082 04 - CLASIFICACIÓN DECIMAL DEWEY | |
| Clasificación | 615.85 / W551a |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Agentes antiretrovirales |
| Subdivisión general | farmacología |
| 9 (RLIN) | 99707 |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Agentes antiretrovirales |
| Subdivisión general | terapéutica |
| 9 (RLIN) | 99707 |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Farmacologia y terapeutica |
| 9 (RLIN) | 110416 |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Medicina |
| 9 (RLIN) | 115965 |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Infecciones del vih |
| Subdivisión general | terapia de droga |
| 9 (RLIN) | 113280 |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Terapia antiretroviral |
| 9 (RLIN) | 133153 |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Terapia antiretroviral altamente activa |
| 9 (RLIN) | 133154 |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Terapias |
| 9 (RLIN) | 133213 |
| 650 14 - MATERIA GENERAL | |
| Término de materia o nombre geográfico como elemento inicial | Salud |
| 9 (RLIN) | 130891 |
No items available.